跳至主要内容
临床试验/NCT02662868
NCT02662868已完成不适用

Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments

Latin American Cooperative Oncology Group24 个研究点 分布在 1 个国家目标入组 767 人开始时间: 2015年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
767
试验地点
24
主要终点
Description of sociodemographic and socioeconomics characteristics associated to diagnostic and treatment of metastatic breast cancer in Brazil

研究概览

简要总结

The purpose of this study is to describe demographics and socioeconomics characteristics associated to the diagnosis of metastatic breast cancer in Brazil.

详细描述

The primary aim of this study is to characterize patients and treatments of metastatic breast cancer in Brazil. Other specific aims are:

  • to describe patients demographics and socioeconomic characteristics
  • to describe the BC pathological characterization
  • to describe treatment (describe each treatment with dates start-end, cycles, dosing, sequence and line of treatment, reason for discontinuation)
  • to analyze patients outcome (time to progression, site of metastasis, progression free survival (PFS), overall survival (OS), skeletal related events (SRE))

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women > 18 years old
  • Patients diagnosed with de novo or recurrent metastatic breast cancer during the period of January to December 2012
  • Any invasive breast cancer histology and subtype

排除标准

  • Male breast cancer

结局指标

主要结局

Description of sociodemographic and socioeconomics characteristics associated to diagnostic and treatment of metastatic breast cancer in Brazil

时间窗: 8 months

次要结局

  • Description of demographic characteristics of metastatic breast cancer patients(8 months)
  • Type of treatment after the diagnosis of metastatic breast cancer(8 months)
  • The clinical and pathological characteristics of patients with metastatic breast cancer(8 months)
  • Prior treatment for breast cancer before metastatic disease(8 months)
  • The description of the clinical outcome of the patient diagnosed with metastatic breast cancer(8 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (24)

Loading locations...

相似试验